GPR30 agonist-1
Modify Date: 2025-11-29 10:11:50
GPR30 agonist-1 structure
|
Common Name | GPR30 agonist-1 | ||
|---|---|---|---|---|
| CAS Number | 415919-74-3 | Molecular Weight | 374.25 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C19H17BrFNO | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of GPR30 agonist-1GPR30 agonist-1 is a G protein-coupled receptor 30 (GPR30) agonist. GPR30 agonist-1 exerts vasorelaxant effects[1]. |
| Name | GPR30 agonist-1 |
|---|
| Description | GPR30 agonist-1 is a G protein-coupled receptor 30 (GPR30) agonist. GPR30 agonist-1 exerts vasorelaxant effects[1]. |
|---|---|
| Related Catalog | |
| In Vivo | GPR30 agonist-1 (compound 5408-0877) (1 nM-10 μM) induces a concentration-dependent relaxation in carotid arteries from both male and female rats. GPR30 agonist-1-induced relaxation is abolished by endothelium removal and abrogated in the presence of the nitric oxide synthase inhibitor NG-nitro-l-arginine methyl ester (100 μM)[1]. |
| References |
| Molecular Formula | C19H17BrFNO |
|---|---|
| Molecular Weight | 374.25 |
| InChIKey | YGLAUQAYNBUDIJ-BIENJYKASA-N |
| SMILES | COc1ccc(Br)cc1C1Nc2ccc(F)cc2C2C=CCC21 |